Recurrent WHO Grade III Glioma
specificThe reemergence of a WHO grade 3 glioma after a period of remission.
10
Centers
10
Active Trials
—
Cancer Funding
Top Centers for Recurrent WHO Grade III Glioma(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 70.8 |
| 2 | Duke Cancer InstituteDurham, NC NCI Comprehensive High-Volume Research Center | 70.8 |
| 3 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 70.8 |
| 4 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 55.0 |
| 5 | NCI Comprehensive Active Research Program | 55.0 |
| 6 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.0 |
| 7 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.0 |
| 8 | NCI Comprehensive | 39.3 |
| 9 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 39.3 |
| 10 | Cleveland Clinic Cancer CenterCleveland, OH | 39.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →